Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: Cyclometallated iridium complexes having triphenylene or aza triphenylene and bulky alkyl substitution that can be used as emitters in OLEDs to improve the external quantum efficiency (EQE) and lifetime of OLEDs are disclosed.

Abstract: A compound having a stoichiometry formula of BiL3, where each L has a formula of where each Z1 and Z2 is O, S, NR, or PR; Z3 is C; Z1, Z2, the single dashed line represent a bond to Bi; and n is an integer. In these structures, LA can be aryl or heteroaryl, which can be substituted. Substituents RL, R, LC, and RLC can be selected from a variety of substituents. In the first formula, at least one of the following is true: (1) LA includes a 5-membered ring; (2) LA includes a condensed ring system of at least three rings; (3) at least one RL is a non-fused aryl or heteroaryl moiety; or (4) n is at least 2 with two different RL's and LA-(RL)n is asymmetrical. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.

Abstract: A novel compound is disclosed which includes a ligand LA of Formula II, wherein: ring B is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently selected from the group consisting of C, N, and CR; at least one pair of adjacent X1 to X4 are each C and fused to Formula V where indicated by “”; X5 to X12 are each independently C or N; the maximum number of N within a ring is two; Z and Y are each independently selected from the group consisting of O, S, Se, NR?, CR?R?, SiR?R?, and GeR?R?; RB and RC each independently represents zero, mono, or up to a maximum allowed substitutions to its associated ring; each of RB, RC, R, R?, and R? is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, su

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, Ring A is a 5-membered or 6-membered ring, and moiety G has a structure of where the dashed line marked with * is coordinated to Ir; the dashed line marked with # is bonded to Ring A; Y is selected from the group consisting of BR, BRR?, NR, PR, O, S, Se, C?O, C?S, C?Se, C?NR, C?CRR?, S?O, SO2, CR, CRR?, SiRR?, and GeRR?. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are organometallic compounds including a ligand LA of Formula I

Abstract: A composition is disclosed that includes a first compound capable of functioning as a host in an emissive layer of an OLED at room temperature; and a second compound that includes a ligand LA of Formula III where ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; where R represents two adjacent substituents that are joined together to form a ring that is fused to ring B, and R has a structure of Formula IV or Formula V disclosed herein.

Abstract: A compound comprising a first ligand LA of Formula I, is disclosed. In the structure of Formula I, ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z1-Z4 are each independently C or N; at least two consecutive Z1-Z4 are C, and are fused to a structure of Formula II or Formula III Y1; Y1 and Y2 are each independently O, S, Se, CRR?, SiRR?, or GeRR?; each RA, RB, RC, R, and R? is a hydrogen or a substituent; and any two substituents may be joined or fused together to form a ring. In the compound, LA is complexed to a metal M by the dashed lines in Formula I to form a five-membered chelate ring, and M has an atomic weight greater than 40. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: Provided are organometallic compounds having a structure of Also provided are formulations that include these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Novel Iridium complexes having three different bidentate ligands useful for phosphorescent emitters in OLEDs are disclosed. At least one of the three different bidentate ligands is a carbene ligand.

Abstract: Provided are transition metal compounds having 5-membered carbocyclic or heterocyclic ring in a unique configuration of fused rings per Formula I The compounds show improved phosphorescent emission in red to near IR region and are useful as emitter materials in organic electroluminescence device.

Abstract: A compound comprising a first ligand LA comprising a structure of Formula I, is provided. In Formula I, moieties A, B, C, and D are each independently a monocyclic ring or a multicyclic fused ring system; each of X1 to X8 is C or N; each independently represents a single bond or a double bond; each of L1, L2, L3, and L4 is independently a direct bond or a linking group; each R, R?, R?, RA, RB, RC, and RD is a hydrogen or a General Substituent; any two adjacent R, R?, R?, RA, RB, RC, and RD may be joined or fused to form a ring; and LA is coordinated to a transition metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of a first ligand LA of Formula I, is provided. In Formula I, moieties A and B are each a monocyclic ring or a polycyclic fused-ring system; Z1 to Z4 are each C or N; K is a direct bond, O, or S; each RA and RB is independently a hydrogen or a General Substituent; at least one RA or RB is R*, wherein R* has a structure of Formula II, ---L-GeR1R2R3; L is a direct bond or an organic linker; and LA is coordinated to a metal M by the dashed lines; and metal M is selected from Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, or Cu.

Abstract: Provided is a compound including a first ligand LA of Formula I In Formula I, ring C is a 5- or 6-membered ring; each of X1 to X8 is C or N; one of X1 to X4 is C and is connected to ring C, and one of X1 to X4 is N and is coordinated to a metal M; Y is a divalent linker; K is a direct bond, O, or S; each R?, R?, RA, RB, and RC is hydrogen or a general substituent; at least one of RA or RB comprises an electron-withdrawing group; at least one of RB is a cyclic group; and metal M is selected from Os, Ir, Pd, Pt, Cu, Ag, and Au. Formulations, devices, and consumer products comprising the compound are also disclosed.

Abstract: A compound comprising a first ligand LA of Formula I, in provided. In Formula I, moiety X is a fused multicyclic ring system comprising two or more rings; rings A and B are independently a 5- or 6-membered carbocyclic or heterocyclic ring; Z1, Z2, and Z3 are each C or N; K3 and K4 are each a direct bond, O, or S; each RA, RB, and RX is hydrogen or a substituent; and at least one of the following conditions is true: (1) ring B is partially or fully deuterated, or (2) at least one RB is an aryl or heteroaryl group that is partially or fully deuterated. The ligand LA is coordinated to a metal M through the dashed lines, and any two substituents except an RX with an RB may be joined to form a ring. Formulations, OLEDs, and consumer products containing these compounds are also provided.

Abstract: A compound having a formula of M(LA)p(LB)q(LC)r, where LA has a structure of Formula I, LB is a bidentate ligand; and LC has a structure of Formula II, is provided. In Formula I and Formula II, the compound can be homoleptic or heteroleptic and can include up to three different ligands; K3 and K4 are each independently a direct bond, O, or S; each of moiety A and moiety B represents a monocyclic ring or a polycyclic, fused-ring structure; each of Z1 and Z2 is C or N; and at least one of RA, RB, RC1, RC2, or RC3 comprises a structure of Formula III, In Formula III, L is bivalent organic linker, and Z is Si or Ge. Each RA, RB, RC1, RC2, and RC3 is independently hydrogen or a General Substituent, and each of R1, R2, and R3 is a General Substituent. Formulations, OLEDs, and consumer products including such compounds are also provided.

Abstract: Disclosed is a compound including a ligand LA of Formula I where each of moiety A and moiety B is independently a monocyclic or polycyclic ring structure including 5-membered and/or 6-membered carbocyclic or heterocyclic rings; where moiety B includes a structure of Formula II These compounds are useful as a component in the emissive layer of OLEDs.

Abstract: Provided are organometallic compounds comprising a first ligand LA which is based on a structure of fused five and six-membered rings according to Formula I as described herein and their various uses including as emitters in devices. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these compounds.

Abstract: A compound of Formula I is provided. In Formula I, ring A is a heterocyclic ring; ring B is a 5- or 6-membered ring, and rings C and D are 6-membered rings; one of Z1, Z2, and Z3 is N and the remainder are C; at least one of K1, K2, and K3 is O or S; one of L1 and L2 is absent and the other one is a direct bond or a linker; when m=0, L1 is not present and X1 is NRA?; each R, R?, R?, RA?, RA, RB, RC, and RD is independently hydrogen or a substituent selected from the general substituents defined herein; and any two substituents may be joined or fused together to form a ring. Formulations, OLEDs, and consumer products incorporating such compounds are also provided.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.